NEKTAR

Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system

[ medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles ]